Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric P Hanson

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Clinical and Translational Science|March 6, 2026
Early Development of Ocadusertib, a Selective Receptor-Interacting Serine/Threonine-Protein Kinase 1 InhibitorSimon J Shaw, Vanessa C Taylor, Jonathan T Sims, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 24, 2016
Recruitment of A20 by the C-terminal domain of NEMO suppresses NF-κB activation and autoinflammatory diseaseJevgenia Zilberman-Rudenko, Linda Monaco Shawver, Alex W Wessel, et al.
Nature Communications|April 13, 2018
Somatic activating mutations in MAP2K1 cause melorheostosisHeeseog Kang, Smita Jha, Zuoming Deng, et al.
The Journal of Experimental Medicine|April 2, 2020
Somatic SMAD3-activating mutations cause melorheostosis by up-regulating the TGF-β/SMAD pathwayHeeseog Kang, Smita Jha, Aleksandra Ivovic, et al.
The Journal of Clinical Investigation|March 15, 2022
Genetically programmed alternative splicing of NEMO mediates an autoinflammatory disease phenotypeYounglang Lee, Alex W Wessel, Jiazhi Xu, et al.
The Journal of Experimental Medicine|February 27, 2013
Loss-of-function mutations in the IL-21 receptor gene cause a primary immunodeficiency syndromeDaniel Kotlarz, Natalia Ziętara, Gulbu Uzel, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 22, 2022
The 2021 European Alliance of Associations for Rheumatology/American College of Rheumatology Points to Consider for Diagnosis and Management of Autoinflammatory Type I Interferonopathies: CANDLE/PRAAS, SAVI, and AGSKader Cetin Gedik, Lovro Lamot, Micol Romano, et al.
Annals of the Rheumatic Diseases|January 28, 2022
The 2021 European Alliance of Associations for Rheumatology/American College of Rheumatology points to consider for diagnosis and management of autoinflammatory type I interferonopathies: CANDLE/PRAAS, SAVI and AGSKader Cetin Gedik, Lovro Lamot, Micol Romano, et al.
Nature Genetics|December 8, 2015
Loss-of-function mutations in TNFAIP3 leading to A20 haploinsufficiency cause an early-onset autoinflammatory diseaseQing Zhou, Hongying Wang, Daniella M Schwartz, et al.
The Journal of Clinical Investigation|December 25, 2019
Distinct interferon signatures and cytokine patterns define additional systemic autoinflammatory diseasesAdriana A de Jesus, Yangfeng Hou, Stephen Brooks, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Clinical and Translational Science|March 6, 2026
Early Development of Ocadusertib, a Selective Receptor-Interacting Serine/Threonine-Protein Kinase 1 InhibitorSimon J Shaw, Vanessa C Taylor, Jonathan T Sims, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 24, 2016
Recruitment of A20 by the C-terminal domain of NEMO suppresses NF-κB activation and autoinflammatory diseaseJevgenia Zilberman-Rudenko, Linda Monaco Shawver, Alex W Wessel, et al.
Nature Communications|April 13, 2018
Somatic activating mutations in MAP2K1 cause melorheostosisHeeseog Kang, Smita Jha, Zuoming Deng, et al.
The Journal of Experimental Medicine|April 2, 2020
Somatic SMAD3-activating mutations cause melorheostosis by up-regulating the TGF-β/SMAD pathwayHeeseog Kang, Smita Jha, Aleksandra Ivovic, et al.
The Journal of Clinical Investigation|March 15, 2022
Genetically programmed alternative splicing of NEMO mediates an autoinflammatory disease phenotypeYounglang Lee, Alex W Wessel, Jiazhi Xu, et al.
The Journal of Experimental Medicine|February 27, 2013
Loss-of-function mutations in the IL-21 receptor gene cause a primary immunodeficiency syndromeDaniel Kotlarz, Natalia Ziętara, Gulbu Uzel, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 22, 2022
The 2021 European Alliance of Associations for Rheumatology/American College of Rheumatology Points to Consider for Diagnosis and Management of Autoinflammatory Type I Interferonopathies: CANDLE/PRAAS, SAVI, and AGSKader Cetin Gedik, Lovro Lamot, Micol Romano, et al.
Annals of the Rheumatic Diseases|January 28, 2022
The 2021 European Alliance of Associations for Rheumatology/American College of Rheumatology points to consider for diagnosis and management of autoinflammatory type I interferonopathies: CANDLE/PRAAS, SAVI and AGSKader Cetin Gedik, Lovro Lamot, Micol Romano, et al.
Nature Genetics|December 8, 2015
Loss-of-function mutations in TNFAIP3 leading to A20 haploinsufficiency cause an early-onset autoinflammatory diseaseQing Zhou, Hongying Wang, Daniella M Schwartz, et al.
The Journal of Clinical Investigation|December 25, 2019
Distinct interferon signatures and cytokine patterns define additional systemic autoinflammatory diseasesAdriana A de Jesus, Yangfeng Hou, Stephen Brooks, et al.
Pageof 2